Quarraisha Abdool Karim Selected Research

Quarraisha Abdool Karim Research Topics

Disease

23	Infections 01/2022 - 03/2007
20	HIV Infections (HIV Infection) 12/2021 - 06/2004
14	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 06/2004
6	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019 - 08/2012
5	Inflammation (Inflammations) 01/2021 - 12/2014
4	Disease Progression 01/2022 - 01/2017
4	HIV Seropositivity 01/2020 - 12/2011
4	Tuberculosis (Tuberculoses) 02/2014 - 06/2004
3	Breakthrough Infections 01/2022 - 06/2012
3	Bacterial Vaginosis 01/2021 - 12/2014
2	COVID-19 01/2022 - 11/2021
2	Superinfection 10/2018 - 03/2014
1	Communicable Diseases (Infectious Diseases) 07/2020
1	Papillomavirus Infections 11/2019
1	Reinfection 10/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2016
1	Necrosis 05/2016
1	Asymptomatic Infections 05/2016
1	Trichomonas Infections 12/2014
1	Chronic Hepatitis B 09/2013
1	Vaginal Discharge 01/2012

Drug/Important Bio-Agent (IBA)

18	Tenofovir (Viread)FDA Link 01/2022 - 09/2010
11	Anti-Infective Agents (Microbicides)IBA 01/2017 - 05/2010
8	CytokinesIBA 01/2022 - 01/2012
5	Biological ProductsIBA 11/2019 - 05/2010
4	AIDS VaccinesIBA 01/2020 - 05/2010
3	InterferonsIBA 11/2021 - 07/2015
3	VaccinesIBA 01/2021 - 06/2012
3	Broadly Neutralizing AntibodiesIBA 01/2021 - 10/2017
3	AntibodiesIBA 01/2020 - 11/2012
2	ChemokinesIBA 01/2022 - 07/2015
2	Immunoglobulin G (IgG)IBA 12/2021 - 10/2017
2	Antiviral Agents (Antivirals)IBA 11/2021 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2016
2	Neutralizing AntibodiesIBA 01/2020 - 10/2018
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2017 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2015
2	RNA (Ribonucleic Acid)IBA 12/2016 - 01/2012
2	InterleukinsIBA 05/2016 - 07/2015
2	AcidsIBA 10/2011 - 02/2010
1	SuspensionsIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Ad26COVS1IBA 01/2022
1	Immunoglobulin M (IgM)IBA 12/2021
1	Immunoglobulin IsotypesIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Lopinavir FDA Link 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Interferon beta-1a FDA Link 11/2021
1	remdesivirIBA 11/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	EpitopesIBA 10/2018
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	IntegrinsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Polysaccharides (Glycans)IBA 10/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2016
1	HLA-B Antigens (HLA-B)IBA 12/2016
1	HLA-B57 antigenIBA 12/2016
1	Chemokine CX3CL1IBA 05/2016
1	Chemokine CCL22IBA 05/2016
1	Interleukin-10 (Interleukin 10)IBA 07/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2015
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 07/2015
1	Interleukin-7 (Interleukin 7)IBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015
1	insulin receptor-related receptor (IRR)IBA 03/2014
1	Opiate AlkaloidsIBA 12/2011
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 09/2010
1	Reverse Transcriptase InhibitorsIBA 09/2010
1	NucleotidesIBA 09/2010
1	efavirenz (Sustiva)FDA Link 02/2010
1	Didanosine (Videx)FDA LinkGeneric 02/2010
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2010
1	Lamivudine (Epivir)FDA Link 02/2010
1	Explosive Agents (Explosives)IBA 06/2004

Therapy/Procedure

7	Therapeutics 07/2020 - 06/2004
2	Art Therapy 10/2018 - 10/2011
2	Highly Active Antiretroviral Therapy (HAART) 03/2007 - 06/2004
1	Contraception (Birth Control) 01/2022
1	Length of Stay 11/2021
1	Condoms (Condom) 09/2014